Camilleri, Michael http://orcid.org/0000-0001-6472-7514
Zhernakova, Alexandra
Bozzarelli, Isotta http://orcid.org/0000-0002-9085-1583
D’Amato, Mauro http://orcid.org/0000-0003-2743-5197
Article History
Accepted: 29 June 2022
First Online: 10 August 2022
Competing interests
: M.C. has received funding for single-centre pharmacodynamic studies from VANDA Pharmaceuticals and NGM Pharmaceuticals. M.D’A. has received financial support from QOL Medical, in the form of unrestricted research grants. A.Z. and I.B. declare no competing interests.